Bitcoin dips under $63,000 and history says more pain ahead before bottom forms
Bitcoin extends overnight weakness amid renewed concerns over President Trump's tariffs.
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
Coinbase, Robinhood and Circle are expanding into stablecoins, payments and prediction markets, but their latest earnings show how hard it is to escape cry...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Bitcoin extends overnight weakness amid renewed concerns over President Trump's tariffs.
The wellness platform's results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.
"Within a week or two after the deadline to contest the will expired, my stepmother sent me an email stating she would not share anything."
Bitcoin slides, falls below $65k amid whale selling, Trump tariff saga
Grey expands business banking with USD accounts and stablecoin support
Independent Legal Opinion Confirms Salvium is a Privacy Coin that is Compliant for EU MiCA Regulated Exchanges
HERNDON, Va., February 23, 2026--Microsoft has approved Everfox's Trusted Thin Client product as the first Cross Domain secure access solution for Microsof...
Tom Lee's Ethereum-focused firm continues buying into the crypto market weakness, now 4.42 million ETH tokens, or about 3.66 percent of the total supply.
With Nvidia earnings on tap as the stock meanders, use Stock Checkup or explore the revamped MarketSurge to apply rules for how to invest.
United Homes stock tumbles on Stanley Martin buyout deal
Citrini ResearchâEUR(TM)s 2028 scenario imagines AI turbocharging corporate profits, while hollowing out consumer demand and quietly migrating global payme...
Novo Nordisk slump wipes out last Wegovy-era gains after trial setback